Post Profile

Taxotere Multidistrict Litigation Transferred

In 1996, the Food and Drug Administration (“FDA”) approved Taxotere “for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy.”  However, women claim that Sanofi- Aventis breast cancer drug Taxotere has caused them to permanently lose their hair. Plaintiffs sued Sanofi-Aventis, the manufacturer of Taxotere claiming the company.
read more


Related Posts

Lilly's diabetes drug Jardiance cuts risk of cardiovascular death: FDA

Health : Reuters: Health

(Reuters) - The U.S Food and Drug Administration said on Friday it had approved Eli Lilly and Co and Boehringer Ingelheim Pharmaceuticals Inc's drug, Jardiance, to reduce the risk of cardiovascular death in patients with type 2 diab...

New Drug for Patients with Late-Stage Lung Cancer

Health : Newswise Medical News

A new drug has been approved by the FDA in the fight against lung cancer. Tecentriq is being used by patients like Cornelius Bresnan, who had late-stage cancer.

Kadcyla For Late-Stage Breast Cancer Approved By FDA

Health : Medical News Today

Kadcyla (ado-trastuzumab emtansine), a new medication for the treatment of HER2-positive, metastatic breast cancer, has been approved by the Food and Drug Administration (FDA), USA. Metastatic, also known as late-stage, means the ca...

Stivarga® (regorafenib) Tablets Approved By U.S. FDA For Treatment Of Patients With Locally Advanced, Unresectable Or Metastatic GIST

Health : Medical News Today

Bayer HealthCare and Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) have announced that the U.S. Food and Drug Administration (FDA) approved Bayer's Stivarga® (regorafenib) tablets to treat patients with locally advanced, unresectable or...

New Immunotherapy Approved for Metastatic Bladder Cancer

Health : Mayo Clinic News Blog

Patients with metastatic bladder cancer have few treatment options after failure of chemotherapy until now. In early May, the U.S. Food and Drug Administration (FDA) approved the immunological drug Atezolizumab to treat metastatic b...


Copyright © 2016 Regator, LLC